ASTARABINE Trademark

Trademark Overview


On Tuesday, May 10, 2022, a trademark application was filed for ASTARABINE with the United States Patent and Trademark Office. The USPTO has given the ASTARABINE trademark a serial number of 97403419. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, May 29, 2024. This trademark is owned by BioSight Ltd.. The ASTARABINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing arabinofuranosyl derivatives for the treatment of cancer
astarabine

General Information


Serial Number97403419
Word MarkASTARABINE
Filing DateTuesday, May 10, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, May 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations containing arabinofuranosyl derivatives for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioSight Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAirport City, Lod 7019802
IL

Party NameBioSight Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAirport City, Lod 7019802
IL

Trademark Events


Event DateEvent Description
Friday, May 13, 2022NEW APPLICATION ENTERED
Monday, May 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 27, 2023ASSIGNED TO EXAMINER
Thursday, March 2, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, March 2, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, March 2, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 2, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, March 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 29, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2023SOU EXTENSION 1 FILED
Wednesday, November 29, 2023SOU EXTENSION 1 GRANTED
Thursday, November 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU EXTENSION 2 GRANTED
Wednesday, May 29, 2024SOU EXTENSION 2 FILED
Thursday, May 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED